350 rub
Journal Technologies of Living Systems №6 for 2013 г.
Article in number:
Relationship between endotelin-1, von willebrand factor and platelet status indices in patients with coronary artery disease
Keywords: endothelial dysfunction aggregation activity von Willebrand factor platelet status
Authors:
E.I. Sokolov, R. Shtin, N.V. Bayurova, V.V. Vikentyev, A.G. Goncharova, L.H. Bragin, А.Е. Severin
Abstract:
In modern domestic and foreign literature many works indicating participation of immunity mechanisms in pathogenesis of many diseases of cardiovascular system, including the coronary heart disease (IBS) which morphological substratum in most cases is atherosclerotic defeat of coronary vessels are executed. We carried out a comprehensive evaluation of cellular and humoral immunity, nonspecific inflammation markers and their relationship to the thickness of the intima-media of the carotid arteries and the impact of changes in these parameters on the nature of coronary artery disease. The study included 44 patients with chronic forms of coronary artery disease and 35 healthy individuals. Shows the activation of predominantly innate immunity, subpopulations of T-lymphocytes responsible for the production of proinflammatory cytokines in patients with coronary artery disease. A positive correlation between the level of C-reactive protein, circulating immune complexes, the thickness of the intima-media of the carotid arteries, and CD4 + CD25 +-T-lymphocytes, CD56, 16 + - NK-cells in patients with coronary artery disease and the severity of coronary artery disease, angina functional class and the development of coronary events. At sick IBS the changes of mainly congenital immunity which are showing in activation of NK lymphocytes (by CD16, CD 56), CD 4+CD25 +, with regulatory activity concerning synthesis are noted about - and anti-inflammatory cytokines, extent of change of the specified links of immunity reflects weight of a current of IBS. CRB is one of the most important prognostic markers of character of a current of IBS, development of complications. The thickness of a complex of intima-media of carotids arteries expressiveness of atherosclerotic defeat of an arterial wall and has prognostic value in character of a current of IBS.
Pages: 57-64
References

  1. Ageev F.T. Rol' e'ndotelial'noj disfunkczii v razvitii i progressirovanii serdechno-sosu­disty'x zabolevanij // Serdechnaya nedostatochnost'. 2003. № 1. S. 22 - 25.
  2. Almazov V.A., Berkovich O.A., Sitnikova M.Ju. i dr. E'ndotelial'naya disfunkcziya u bol'ny'x s debyutom ishemicheskoj bolezni v raznom vozraste // Kardiologiya. 2001. № 5. S. 26 - 29.
  3. Almazov V.A., Gurevich V.S., Popov Ju.G. Struktura i funkcziya reczeptorov tromboczitov cheloveka // Gematologiya i transfuziologiya. 1990. № 10. S. 25 - 29.
  4. Baluda M.V., Tlepushkov I.K. O diagnostike pretromboticheskogo sostoyaniya sistemy' gemostaza // Tromboz, gemostaz i reologiya. 2001. № 5. S. 79 - 82.
  5. Vavilova T.V. Gemostaziologiya v klinicheskoj praktike. SPb.: Izdatel'stvo SPbGMU im. akad. I.P. Pavlova. 2005. 92 s.
  6. Gomazkov O.A. Sistema e'ndotelinovy'x peptidov: mexanizmy' e'ndovaskulyarny'x patologij // Kardiologiya. 2000. № 1. S. 32 - 39.
  7. Gomazkov O.A. E'ndotelin v kardiologii: molekulyarny'e, fiziologicheskie i patologicheskie aspekty' (obzor) // Kardiologiya. 2001. № 2. S. 50 - 58.
  8. Gosudarstvenny'j doklad o sostoyanii zdorov'ya naseleniya Rossijskoj Federaczii v 2002 godu // Zdravooxranenie RF. 2004. № 1. S. 3 - 18.
  9. Mordovin V.F., Ripp T.M., Sokolov S.E. i dr. Dinamika pokazatelej e'ndotelijzavisimoj vazodilataczii i gipotenzivnaya e'ffektivnost' e'nalaprila u paczientov s arterial'noj gipertenziej // Kardiologiya. 2001. № 6. S. 31 - 33.
  10. Oganov R.G., Maslennikova G.Ja. Smertnost' ot serdechno-sosudisty'x i drugix xronicheskix neinfekczionny'x zabolevanij sredi trudosposobnogo naseleniya Rossii. Kardiovaskulyarnaya terapiya i profilaktika. 2002. № 3. S. 4 - 8.
  11. Papayan L.P. Sovremennoe predstavlenie o mexanizme regulyaczii sverty'vaniya krovi // Tromboz, gemostaz i reologiya. 2003. №2. S. 7 - 11.
  12. Pataraya S.A.. Preobrazhenskij D.V.. Sidorenko B.A., Masenko V.P. Bioximiya i fiziologiya semejstva e'ndotelinov // Kardiologiya. 2000. T. 40. № 6. S. 78 - 85.
  13. Sergienko V.I., Bondareva I.B. Matematicheskaya statistika v klinicheskix issledovaniyax. M.: Ge'otarmed, 2001.
  14. Shushlyapin O.I., Kononenko L.G., Manik I.M. Faktor Villebranda i ego rol' v disfunkczii e'ndoteliya pri ishemicheskoj bolezni serdcza: diagnostika, kriterii prognoza i perspektivny'e podxody' k terapii // Kardiologiya. 2001. № 2. S. 32 - 39.
  15. Jushhuk E.N., Vasyuk Ju.A., Xadzegova A.B. i dr. E'ndotelial'naya disfunkcziya pri zabolevaniyax serdechno-sosudistoj sistemy' i metody' ee korrekczii // Klinicheskaya farmakologiya i terapiya. 2005. T. 14. № 3. S. 85 - 88.
  16. Anderson T.J. Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction // Heart Failure Rev. 2003. V. 8. № 1. P. 71 - 86.
  17. Anderson T.J., Meredith I.T., Charbonneau F., Yeung A.C., Frei V., Selwyn A.P., Ganz P. Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans // Circulation. 1996. V. 93. № 9. P. 1647 - 1650.
  18. Balligand J.L. New mechanisms of LDL-cholesterol induced endothelial dysfunction; correction by statins // Bull. Mem. Acad. R. Med. Belg. 2002. V. 157. № 10. P. 427 - 431.
  19. Bassenge E. Endothelial regulation of coronary tone // Endothelial regulation of vascular tone. N.Y. etc.: Marcel Dekker, inc., 1992. P. 225 - 264.
  20. Berliner J.A., Navab M., Fogelman A.M. et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics // Circulation. 1995. V. 91. P. 2488 - 2496.
  21. Blann A.D. Von Willebrand factor and the endothelium in vascular disease // Brit. J. Biomed. Sci. 1993. V. 50. P. 124 - 134.
  22. Blann A.D., Sheeran T.P., Emery P. Von Willebrand factor: increased level are leated to poor prognosis in systemic sclerosis and not to tissue autoantibodies // Brit. J. Biomed. Sci. 1997. V. 54. P. 670 - 673.
  23. Bowie E.J.W. The role of von Willebrand factor in thrombosis // Thrombosis and its management. Edinburg: Churchill Livingstone. 1993. P. 134 - 140.
  24. Davignon J., Ganz P. Role of endothelial dysfunction in atherosclerosis // Circulation. 2004. V. 1 09(23 Suppl 1). P. III27 - 32.
  25. Harrison D.G. Cellular and molecular mechanisms of endothelial cell dysfunction // J. Clin. Invest. 1997. V. 19. P. 23 - 27.
  26. Horio T. Heart failure and circulatory peptides // Nippon Naika Gakkai Zasshi. 2005. V. 94. P. 201 - 207.
  27. Khan I.A. Role of endothelin-1 in acute myocardial infarction // Chest. 2005. V. 127. P. 1474 - 1476.
  28. Negrusz-Kawechka M. The role of endothelins in human cardiovascular disease // Pol. Mercuriusz. Lek. 2001. V. 11. P. 444 - 446.
  29. Teerlink J.R. Endothelins: pathophysiology and treatment implication in chronic heart failure // Current Heart Failure Reports. 2005. V. 2. P. 191 - 197.
  30. Vanhoutte P.M. Endothelial control of vasomotor function: from health to coronary disease // Circ. J. 2003. V.67. P. 572 - 575.
  31. Willey K.E., Davenport A.P. Nitric oxide-medulation of the endothelin-1 signaling pathway in the human cardiovascular system // Brit. J. Pharmacology. 2001. V. 132. P. 213 - 220.
  32. Zolk O., Bohm M. The role of the cardiac endothelin system in heart failure // Nephrol. Dial. Transplant. 2000. V.15. P. 758 - 760.
  33. Zolk O., Quattek J., Sitzler G. et al. Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure // Circulation. 1999. V. 99. P. 2118 - 2123.